Has Rebecca Hahn, MD received payments from drug or device companies?

Yes. Drug and device makers reported $175,504 in general payments to Rebecca Hahn, MD across 428 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rebecca Hahn, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rebecca Hahn, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rebecca Hahn, MD

Cardiovascular Disease · New York, NYNPI 1497893077

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (40.3%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 23.5%. Reporting peaked in 2019 at $57,565 and has fallen 91.7% since, to $4,777 in 2025. Among cardiovascular disease clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$175,504in general payments, 2019–2025

Across 428 payments — averaging $410.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$41K
Philips North America LLC$38K
Edwards Lifesciences$37K
Medtronic$37K
Boston Scientific$14K
Baylis Medical Company Inc$4K
plus $4K from 5 others

$98,583in research payments, 2019–2025

Across 12 payments — averaging $8215.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Edwards Lifesciences$74K
Philips North America LLC$13K
Medtronic$7K
Abbott$5K

What the payments were for

Consulting fees$53,55031%
Speaking & faculty fees$31,92418%
Grants$5460%
Travel & lodging$70,79840%
Food & beverage$15,6569%
Education$3,0302%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	124	$41,254
Philips North America LLC	28	$37,580
Edwards Lifesciences	150	$37,060
Medtronic(2 entities)	86	$36,932
Boston Scientific	25	$14,351
Baylis Medical Company Inc	5	$3,933
Siemens Medical Solutions USA, Inc.	1	$2,565
Croivalve Inc	2	$1,549
Abiomed	1	$142
Heartflow, Inc.	5	$118
Boehringer Ingelheim	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

(9520) IGT Devices Undivided$28,582
Mitra Clip system$27,965
CoreValve Evolut$8,274
VersaCross Access Solution$7,583
GENERAL - STRUCTURAL HEART$6,000
MitraClip System$5,500
PASCAL$5,102
COREVALVE EVOLUT R$4,399
Edwards SAPIEN 3 Transcatheter Heart Valve$4,002
NRG needle$3,586
Other$3,535
ACUSON SC2000 Diagnostic Ultrasound System$2,565
EVOQUE$1,544
(5044) MCOT$1,515
(0054) Support function$1,515
Educ Ultrasound$1,515
AMPLATZER Occluders$750
MitraClip$667
Watchman$500
(6554) Peripheral Vascular Undivided$334

How this compares

$175,504 in reported general payments places this provider in the 95th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York →

Medicare billing

Part B allowed, 2024

$69,964

Medicare patients

290

Services billed

470

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in New York

Roger HajjarNew York$5.2M
Gregg StoneNew York$2M
Philippe GenereuxNew York$1.3M
Adam RosenbluthNew York$1.1M
Megha PrasadNew York$813K
Eyal HerzogNew York$645K
Nisha JhalaniNew York$443K
Roxana MehranNew York$432K
Howard WeintraubNew York$328K
Anuradha Lala-TrindadeNew York$324K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →